Possis Receives FDA Clearance for GuardDOG(R) Occlusion System; New Device Allows Physicians to Quickly and Effectively (RedNova)
Possis Medical, Inc. (NASDAQ:POSS), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its GuardDOG(R) Occlusion System for use during the treatment of peripheral vascular disease.

St. Jude Medical Announces FDA Approval and Launch of QuickOpt(TM) Timing Cycle Optimization for Heart Failure and ICD (RedNova)
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval and launch of QuickOpt(TM) Timing Cycle Optimization.

Gen-Probe Receives FDA Clearance to Test Additional Specimen Types for STDs With the APTIMA Combo 2(R) Assay on the (FinanzNachrichten)
SAN DIEGO, Aug. 22 /PRNewswire-FirstCall/ -- Gen-Probe ( Nachrichten ) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing clearance to use the APTIMA Combo 2(R) assay to test two additional kinds of patient samples for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) on the fully automated TIGRIS(R) system.